4//SEC Filing
BERNSTEIN HOWARD PHD MD 4
Accession 0001209191-22-009830
CIK 0001604477other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 5:15 PM ET
Size
5.3 KB
Accession
0001209191-22-009830
Insider Transaction Report
Form 4
BERNSTEIN HOWARD PHD MD
Chief Scientific Officer
Transactions
- Award
Stock Option
2022-02-10+195,000→ 195,000 totalExercise: $6.57Exp: 2032-02-09→ Common Stock (195,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable as to 25% of the underlying securities on February 10, 2023 and in 36 substantially equal monthly installments thereafter.
Documents
Issuer
SQZ Biotechnologies Co
CIK 0001604477
Entity typeother
Related Parties
1- filerCIK 0001262409
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 5:15 PM ET
- Size
- 5.3 KB